Blood Culture Tests Market: Global Industry Analysis and Forecast (2024-2030)

Blood Culture Tests Market size was valued at USD 5.33 Bn. in 2023 and the total Blood Culture Tests revenue is expected to grow by 11 % from 2024 to 2030, reaching nearly USD 11.50 Bn.

Blood Culture Tests Market Overview:

The Blood culture tests are a method for identifying the presence of microorganisms in the blood, such as fungi or bacteria. It determines the underlying cause of bloodstream infection and offers a suitable course of treatment. The total blood count and chemical analysis are two diagnostic tests that are frequently performed in conjunction with blood culture testing. Tests using blood cultures are extremely important in the diagnosis of many infectious disorders. Growth in the market is expected to boost by the growing prevalence of infectious diseases and improvements in diagnostic technology. Additionally, it is expected that an aging population and the demand for quick diagnosis and treatment drive the blood culture testing market. The World Health Organization estimates that over 17.1 million people worldwide pass away each year as a result of infectious diseases. Moreover, it is expected that an increase in R&D spending and public awareness of early diagnosis supports market growth in the forecast period. It is expected that the high cost of breakthrough technology and the shortage of highly qualified personnel hamper the market growth. The market for blood culture tests has been witnessing northward growth thanks to the growing demand for speedy diagnoses and findings. Blood culture tests are more frequently advised as a result of growing rates of hospital-acquired infections, infectious illnesses, and reduced immunity due to high pollution levels. Strict laws in places like North America and Europe, however, are some of the restraining factor for the growth of the market. Having said this, increasing investments in new, cutting-edge research methods are supposed to compensate the decrease in the boost of the market. Since patient awareness is growing and prices are becoming more accessible, market developing economies are expected to witness faster growth rate and same is covered in detail in the report.

Report Scope:

The Blood Culture Tests market's characteristics, size, growth, segmentation, regional breakdowns, market shares, trends, and business plans are all included in the report. Future market dynamics like major trends, segmentation analysis, and key market development and competitive analysis make this report more comprehensive. The report covers effective business strategies, consumer preferences, governmental regulations, recent competitor actions, as well as future business prospects. In-depth financial information about top manufacturers, such as year-after-year sales, revenue growth, CAGR, production cost analysis, and value chain structure, is highlighted in the Blood Culture Tests Market study.Blood Culture Tests MarketTo know about the Research Methodology :- Request Free Sample Report

Blood Culture Tests Market Dynamics:

Market Drivers:

High frequency of infections in the bloodstream

Bloodstream infections acquired in hospitals, or nosocomial infections, are among the major causes of death worldwide. Each year, there are over 255,000 hospital-acquired BSI cases in the US alone. About 33 million individuals worldwide are affected by bloodstream infections each year, which result in 6.1 million fatalities, 3 million infants, and 1.2 million kids developing sepsis. Bloodstream infections are known to affect anywhere between 11% and 28% of patients in Eastern African nations. Bloodstream infection rates in Ghana are thought to be between 9.3% and 11.2%. (Source: Journal of Tropical Medicine, 2019). The frequency of these illnesses lengthens hospital stays overall and raises treatment costs. The demand for sophisticated blood culture techniques that aid in the early diagnosis of infections is expected to increase due to the growing frequency of BSIs. Blood Culture Tests Market

Government Initiatives

Increased government initiatives for the development and manufacture of blood culture test products, increase in healthcare awareness to reduce the risk of infectious diseases, rise in demand for blood culture tests and growing investment in R&D activities by various healthcare companies all contribute to the market's growth. For instance, the biotech business F. Hoffmann-La Roche Ltd. spent $10.27 billion on research and development in 2023. Additionally, throughout the forecast period, the market is expected to increase due to the installation of favourable regulatory frameworks for the research and production of advanced diagnostic goods, including blood culture test products. The growth of the blood culture test market is expected to benefit from the increase in new technology adoption during the forecast period. Market Restraints:

Expensive automated instruments

Automated blood culture equipment is more expensive since it has more sophisticated features and functions. Automated tools like the PCR cost between US$10,050 and US$15,000, and MALDI-TOF MS systems cost between US$151,000 and US$850,000. Owing to their restricted funding, academic research facilities typically cannot afford such expensive systems. The overall cost of ownership of these instruments also rises as a result of the maintenance charges and numerous other indirect expenses. This is a significant barrier to the uptake of automated blood culture equipment, particularly among smaller end users. Market Opportunities: The market for blood culture testing is growing with a focus on emerging economies like China, India, and others in Southeast Asia, the Middle East, and Latin America. The increased aging of the population, the rise in the prevalence of infectious diseases, the growing number of product approvals, and the increasing cost of healthcare are the main causes of the significant growth in these markets. For instance, China's healthcare spending climbed from USD 6.90% of GDP in 2019 to 8.35% of GDP in 2022. These regions' hospitals and reference laboratories adopt cutting-edge equipment, like automated blood culture systems, Thanks to such substantial spending. In consequence, this is expected to present future growth prospects for companies competing in the blood culture testing market. Challenges:

Market exploitation

Several technologically advanced items that offer improved methods for detecting bacteria in the bloodstream have recently been introduced to the market. These cutting-edge technologies are expected to compete with traditional items like polystainers and microscopes on the market, slowing the growth of traditional blood culture testing products. Players need to adopt new technologies to broaden their product portfolio and maintain a competitive position in the market. For market companies with a well-established portfolio of traditional items, this is a difficult task.

Blood Culture Tests Market Segment Analysis:

Based on Product, the growing use of items like blood culture media, assay, kits, reagents, and other accessories for diagnostics applications, and consumables accounted for the highest revenue-generating segment of the blood culture tests market in 2023. The frequent purchasing of consumables is yet another significant factor fueling the segment's growth. Because of product advances, the instruments industry is expected to grow significantly throughout the forecast period. In hospitals and other diagnostic labs, automated systems, incubators, colony counters, microscopes, and gram strainers are frequently employed. Companies that provide diagnostic services are concentrating on creating cutting-edge goods to meet customer demand. For instance, the top diagnostics business bioMérieux announced in July that its VIRTUO device, a cutting-edge system for continuous monitoring of blood culture for microbial identification, has obtained CE certification. The growing incidence of BSI and infectious illnesses has resulted in a strong demand for enhanced blood culture testing products. Modern automated techniques produce very accurate findings quickly and with little chance of contamination.Blood Culture Tests Market1Based on the Technique, The market is divided into conventional and automated segments based on technique. Owing to the widespread use of the conventional technique by hospitals, independent clinical laboratories, and pathology laboratories in 2023, had the biggest revenue-generating segment. Thanks to technical developments, such as faster and more accurate findings, and increased R&D investments by manufacturers for new product development, the automated blood culture technique sector is expected to exhibit the greatest CAGR during the forecast period. The company's main priorities are the introduction of cutting-edge testing equipment and supplies for its clients. The BD BACTEC FX40 Blood Culture System and the BD EpiCenter Microbiology Data Management System, for instance, were introduced by Becton, Dickinson, and Company in June. China, Japan, India, the U.S., Germany, France, and the U.K. are expected to hold a sizable portion of the market. Some of the reasons that are likely to contribute to the growth include the growing prevalence of infectious diseases, the existence of several diagnostics firms, and the accessibility of a highly developed healthcare infrastructure. Based on Technology, The market is divided into culture-based, molecular, and proteomic segments depending on technology. The segment of technology based on culture had the biggest sales market share in 2023. This is because many laboratories, including hospital, reference, pathology, and doctor's office laboratories, use this technology extensively. The category for molecular technologies is expected to have the highest CAGR throughout the forecast period. Rapid diagnostic methods for identifying bacterial or fungal infections in the blood are in demand owing to manufacturers' increasing R&D expenditures and an increase in the prevalence of infectious disorders. The market is expected to grow as a result of increasing demand for cutting-edge diagnostic tools including microarray, PCR, and Peptide Nucleic Acid—Fluorescent In Situ Hybridization (PNA-FISH). The PNA-FISH technology sub-segment is likely to grow at the highest CAGR during the forecast period as a result of its benefits, including improved accuracy, shorter test times, and increased test specificity. The demand for blood culture testing has increased as a result of growing healthcare infrastructure and increasing disposable income in the Asia Pacific and MEA region. Additionally, it is expected that increased government initiatives to provide healthcare facilities of higher quality, along with the accessibility of new technologies, increase the use of these tests. Based on Application, Blood culture tests are used to find bacteria that spread into the blood in several illnesses, including osteomyelitis, meningitis, pneumonia, kidney infection, and sepsis. Infections with mycobacteria and fungi can also be found using them. As bacterial infection is the most frequent cause of BSI and other infections, the bacterial infections category held the largest market share in terms of revenue in 2018. Additionally, the segment is anticipated to have the greatest CAGR during the forecast period. The segment's growth is anticipated to be fueled by rising healthcare awareness and improved healthcare infrastructure in developing nations like South Africa, Tanzania, China, India, and Argentina. The governments of these nations are working to provide higher-quality medical facilities and diagnostic tools, which encourages adoption even more. Because BSIs are common and sepsis cases are increasing globally, the fungal infections market is expected to increase profitably over the study period. For example, Candida species are the main causative agents of fungal sepsis, which accounts for 10% to 15% of infections associated with healthcare.Blood Culture Tests Market2Based on End-Use, Hospital laboratories held the greatest revenue share of the market in 2018. This is due to an increase in infections that are acquired in hospitals (HAIs). The WHO estimates that developing nations have an infection rate in intensive care units (ICUs) that is two to three times higher than that of industrialized nations. This rate includes infections of the urinary tract (UTIs) and surgical site wounds. Every year, over 8,000 patients in Canada pass away from illnesses acquired in hospitals. Additionally, throughout the forecast period, the hospital laboratory segment is anticipated to grow at the quickest CAGR. The primary driver of the growth is increasing public knowledge of healthcare issues together with actions taken by the government and non-governmental organizations to prevent and control infectious diseases. For instance, to produce national HIV clinical and research guidelines, support HIV and TB programs, and undertake epidemiology training, the Centers for Disease Control and Prevention (CDC) and the government of South Africa worked together. Due to an increase in hospitals outsourcing their blood culture testing to reference laboratories, the reference laboratories market sector is anticipated to grow profitably throughout the forecast period. The reference laboratories are outfitted with cutting-edge diagnostic tools that deliver faster, more accurate, and more dependable results. Academic research labs, bacteriological labs, pathology labs, and doctor's office labs are the further end-use segments. This market category is also anticipated to expand significantly throughout the forecast.

Blood Culture Tests Market Regional Insights:

North America dominated the market with largest revenue market share in 2023. Owing to the presence of numerous significant healthcare organizations like Becton, Dickinson and Company, bioMérieux SA, Thermo Fisher Scientific, Inc., and Roche Diagnostics. Blood Culture Tests MarketThe availability of cutting-edge diagnostics products and the presence of highly developed healthcare infrastructure in European nations like Germany, the U.K., Switzerland, and France are expected to fuel market growth in Europe. Additionally, manufacturers' increasing R&D expenditures for the creation of new products are expected to fuel growth. Because of its high prevalence of infectious diseases and increasing healthcare infrastructure, Asia Pacific is expected to see the highest CAGR during the forecast period. For economic growth, many diagnostic businesses are focusing on Asian nations like China and India. Some of the major drivers of the growth of the regional market in the Asia Pacific include the availability of a sizable base of target consumers and growing disposable income.

Blood Culture Tests Market Scope: Inquire before buying

Blood Culture Tests Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 5.33 Bn.
Forecast Period 2024 to 2030 CAGR: 11% Market Size in 2030: US $ 11.50 Bn.
Segments Covered: by Product Consumables Bacterial Infections Fungal Infections Mycobacterial Infections Assay, Kits, and Reagents Blood Culture Accessories Blood Culture Media  Aerobic  Anaerobic Fungi/Yeast  Others Instrumentso Bacterial Infections Fungal Infections Mycobacterial Infections Automated Blood Culture Systems Laboratory Equipment  Incubators  Colony counters  Microscopes  Gram stainers Software & Services Bacterial Infections Fungal Infections Mycobacterial Infections
by Technique Conventional Automated
by Technology Culture-based Technology Proteomic technology Molecular Technology PCR Microarray NA-FISH
by Application Bacterial Infections Fungal Infections Mycobacterial Infections
by End-Use Hospital Laboratories Reference Laboratories Others

Blood Culture Tests Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Blood Culture Tests Market,Key Players are:

1. Becton 2. Dickinson and Company 3. Thermo Fisher Scientific 4. bioMérieux SA 5. Luminex Corporation 6. Danaher Corporation 7. Bruker Corporation 8. IRIDICA 9. Roche Diagnostics 10.T2 Biosystems 11.Anaerobe Systems 12.OpGen 13.Meditech Technologies India Private Limited 14.Carl Zeiss AG 15.Nikon Corporation 16.BINDER GmbH 17.Biobase Biotech 18.Scenker Biological Technology Co. 19.Bulldog Bio 20.Axiom Laboratories 21.HiMedia Laboratories Frequently Asked Questions: 1] What segments are covered in the Global Blood Culture Tests Market report? Ans. The segments covered in the Blood Culture Tests Market report are based on Product Type and End User. 2] Which region is expected to hold the highest share in the Global Blood Culture Tests Market? Ans. The North America region is expected to hold the highest share in the Blood Culture Tests Market. 3] What is the market size of the Global Blood Culture Tests Market by 2030? Ans. The market size of the Blood Culture Tests Market by 2030 is expected to reach US$ 11.50 Bn. 4] What is the forecast period for the Global Blood Culture Tests Market? Ans. The forecast period for the Blood Culture Tests Market is 2024-2030. 5] What was the market size of the Global Blood Culture Tests Market in 2023? Ans. The market size of the Blood Culture Tests Market in 2023 was valued at US$ 5.33 Bn.
1. Global Blood Culture Tests Market Size: Research Methodology 2. Global Blood Culture Tests Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Blood Culture Tests Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Blood Culture Tests Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Blood Culture Tests Market Size Segmentation 4.1. Global Blood Culture Tests Market Size, by Product (2023-2030) • Consumables o Bacterial Infections o Fungal Infections o Mycobacterial Infections o Blood Culture Media o Aerobic o Anaerobic o Fungi/Yeast o Others o Assay, Kits, and Reagents o Blood Culture Accessories • Instruments o Bacterial Infections o Fungal Infections o Mycobacterial Infections o Laboratory Equipment o Incubators o Colony counters o Microscopes o Gram stainers o Automated Blood Culture Systems • Software & Services o Bacterial Infections o Fungal Infections o Mycobacterial Infections 4.2. Global Blood Culture Tests Market Size, by Technique (2023-2030) • Conventional • Automated 4.3. Global Blood Culture Tests Market Size, by Technology (2023-2030) • Culture-based Technology • Molecular Technology o PCR o Microarray o PNA-FISH • Proteomic technology 4.4. Global Blood Culture Tests Market Size, by Application (2023-2030) • Bacterial Infections • Fungal Infections • Mycobacterial Infections 4.5. Global Blood Culture Tests Market Size, by End-Use (2023-2030) • Hospital Laboratories • Reference Laboratories • Others 5. North America Blood Culture Tests Market (2023-2030) 5.1. North America Blood Culture Tests Market Size, by Product (2023-2030) • Consumables o Bacterial Infections o Fungal Infections o Mycobacterial Infections o Blood Culture Media o Aerobic o Anaerobic o Fungi/Yeast o Others o Assay, Kits, and Reagents o Blood Culture Accessories • Instruments o Bacterial Infections o Fungal Infections o Mycobacterial Infections o Laboratory Equipment o Incubators o Colony counters o Microscopes o Gram stainers o Automated Blood Culture Systems • Software & Services o Bacterial Infections o Fungal Infections o Mycobacterial Infection 5.2. North America Blood Culture Tests Market Size, by Technique (2023-2030) • Conventional • Automated 5.3. North America Blood Culture Tests Market Size, by Technology (2023-2030) • Culture-based Technology • Molecular Technology o PCR o Microarray o PNA-FISH • Proteomic technology 5.4. North America Blood Culture Tests Market Size, by Application (2023-2030) • Bacterial Infections • Fungal Infections • Mycobacterial Infections 5.5. North America Blood Culture Tests Market Size, by End-Use (2023-2030) • Hospital Laboratories • Reference Laboratories • Others 5.6. North America Semiconductor Memory Market, by Country (2023-2030) • United States • Canada • Mexico 6. European Blood Culture Tests Market (2023-2030) 6.1. European Blood Culture Tests Market, by Product (2023-2030) 6.2. European Blood Culture Tests Market, by Technique (2023-2030) 6.3. European Blood Culture Tests Market, by Technology (2023-2030) 6.4. European Blood Culture Tests Market, by Application (2023-2030) 6.5. European Blood Culture Tests Market, by End-Use (2023-2030) 6.6. European Blood Culture Tests Market, by Country (2023-2030) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Blood Culture Tests Market (2023-2030) 7.1. Asia Pacific Blood Culture Tests Market, by Product (2023-2030) 7.2. Asia Pacific Blood Culture Tests Market, by Technique (2023-2030) 7.3. Asia Pacific Blood Culture Tests Market, by Technology (2023-2030) 7.4. Asia Pacific Blood Culture Tests Market, by Application (2023-2030) 7.5. Asia Pacific Blood Culture Tests Market, by End-Use (2023-2030) 7.6. Asia Pacific Blood Culture Tests Market, by Country (2023-2030) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Blood Culture Tests Market (2023-2030) 8.1. Middle East and Africa Blood Culture Tests Market, by Product (2023-2030) 8.2. Middle East and Africa Blood Culture Tests Market, by Technique (2023-2030) 8.3. Middle East and Africa Blood Culture Tests Market, by Technology (2023-2030) 8.4. Middle East and Africa Blood Culture Tests Market, by Application (2023-2030) 8.5. Middle East and Africa Blood Culture Tests Market, by End-Use (2023-2030) 8.6. Middle East and Africa Blood Culture Tests Market, by Country (2023-2030) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Blood Culture Tests Market (2023-2030) 9.1. South America Blood Culture Tests Market, by Product (2023-2030) 9.2. South America Blood Culture Tests Market, by Technique (2023-2030) 9.3. South America Blood Culture Tests Market, by Technology (2023-2030) 9.4. South America Blood Culture Tests Market, by Application (2023-2030) 9.5. South America Blood Culture Tests Market, by End-Use (2023-2030) 9.6. South America Blood Culture Tests Market, by Country (2023-2030) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. Becton 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Dickinson and Company 10.3. Thermo Fisher Scientific 10.4. bioMérieux SA 10.5. Luminex Corporation 10.6. Danaher Corporation 10.7. Bruker Corporation 10.8. IRIDICA 10.9. Roche Diagnostics 10.10. T2 Biosystems 10.11. Anaerobe Systems 10.12. OpGen 10.13. Meditech Technologies India Private Limited 10.14. Carl Zeiss AG 10.15. Nikon Corporation 10.16. BINDER GmbH 10.17. Biobase Biotech 10.18. Scenker Biological Technology Co. 10.19. Bulldog Bio 10.20. Axiom Laboratories 10.21. HiMedia Laboratories

About This Report

Report ID 159435
Category Medical Devices
Published Date January 2024
Updated Date
  • INQUIRE BEFORE BUYING